Summary information	Consolidated Performance					Standalone Performance
	2024	2023	2022	2021	2020	2024	2023	2022	2021	2020
Net Sales	46282	46010	32896	26041	25694	25932	24732	21916	16493	16231
EBITDA *	8593	7659	5968	5121	4614	5399	4963	4115	3174	3069
PBIT *	6686	5785	4822	4126	3569	4672	4218	3465	2559	2399
PBT	6502	5799	4765	3946	3505	4631	4316	3455	2445	2395
PAT	4613	4140	3334	2843	2724	3504	3309	2545	1840	1913
Net Fixed Assets	13917	13698	9057	6754	6540	5741	5322	4527	4293	4344
Net Working Capital	14914	12879	8751	12433	9869	6704	4169	3178	8503	6799
Non Current Investments	1716	1612	1378	1271	1212	10394	10475	9685	2507	2458
Shareholders Networth	31257	28206	23638	21315	18584	22975	20065	17407	15348	13671
Loan Funds	1127	2301	2122	430	616	-	1040	1630	-	-
Ratio Analysis
Performance Ratios
EBITDA / Net Sales %	19	17	18	20	18	21	20	19	19	19
PBIT / Net Sales %	14	13	15	16	14	18	17	16	16	15
Asset Turnover times	1.20	1.32	1.14	1.12	1.25	1.76	1.84	1.51	1.15	1.33
Return on Capital Employed %	20	20	20	20	19	21	21	20	18	18
Return on Equity %	16	16	15	14	15	16	18	16	13	14
International Revenue (net) share %	54	56	45	49	49	24	26	23	25	24
Leverage Ratios
Interest Cover (times)	47	33	106	143	73	130	33	423	1171	872
Debt Equity Ratio (times)	0.04	0.08	0.09	0.02	0.03	-	0.05	0.09	-	-
Debt / Total Assets (times)	0.03	0.06	0.06	0.02	0.03	-	0.04	0.07	-	-
Liquidity Ratio
Current Ratio (times)	3.20	2.74	2.13	3.67	3.79	3.41	2.01	1.62	3.90	4.65
Activity Ratio
Inventory Turnover days	69	63	64	68	74	52	58	58	69	75
Receivable Turnover days	52	44	53	62	65	54	53	54	64	66
Creditors No. of days	50	49	57	51	42	41	48	53	53	46
Cash Cycle days	71	58	60	79	97	65	63	59	80	95
Investor Related Ratios
Earning Per Share	24.27	21.80	17.57	15.01	14.39	18.44	17.43	13.41	9.71	10.11
Dividend Per Share	NA	NA	NA	NA	NA	4.00	3.50	3.50	3.00	2.75
- Interim	NA	NA	NA	NA	1.50	1.50	1.50	1.50	2.75	2.75
- Final (proposed and paid in subsequent year)	NA	NA	NA	NA	2.50	2.00	2.00	1.50	-	-
Dividend Payout %	NA	NA	NA	NA	NA	21.7	20.1	26.1	30.9	32.5
Price to Earnings Ratio	47	39	44	21	23	-	-	-	-	-
Enterprise Value / EBITDA	25	21	24	11	13	NA	NA	NA	NA	NA
Enterprise Value / Net Sales	4.66	3.49	4.41	2.18	2.31	NA	NA	NA	NA	NA

*excluding exceptional income/expenses (Net)